Abstract
Basilar-type migraine (BM) has been recognised in the revised International Classification of Headache Disorders as a distinct clinical entity (subtype of migraine with aura), characterised by disturbing migraine aura clearly originating from the brainstem or from both hemispheres simultaneously affected. It differs from familial and sporadic hemiplegic migraines by the absence of motor deficit. Lamotrigine has been shown to be effective in preventing migraine aura symptoms in typical aura and in some cases of BM. We tried lamotrigine in three female cases of BM.
MeSH terms
-
Adult
-
Basilar Artery / drug effects*
-
Basilar Artery / physiopathology
-
Brain / blood supply
-
Brain / diagnostic imaging
-
Brain / physiopathology
-
Cerebral Arteries / diagnostic imaging
-
Cerebral Arteries / physiopathology
-
Dose-Response Relationship, Drug
-
Female
-
Humans
-
Lamotrigine
-
Menstruation Disturbances / complications
-
Menstruation Disturbances / physiopathology
-
Migraine with Aura / diagnosis
-
Migraine with Aura / drug therapy*
-
Migraine with Aura / physiopathology
-
Sodium Channel Blockers / administration & dosage
-
Tomography, Emission-Computed, Single-Photon
-
Treatment Outcome
-
Triazines / administration & dosage*
Substances
-
Sodium Channel Blockers
-
Triazines
-
Lamotrigine